We went down the path of this (including beginning to IRB process to allow us to publish the findings) but it got derailed by COVID. Having everything preprinted before review makes it more challenging to blind, but we’ve been discussing how to reboot this.

That’s great to hear that this is still being considered. Indeed, preprints make this tricky, but surely there’s a clever solution somewhere.